# Incannex Healthcare Inc. (IXHL) · Edgar & Edgarette company card

> Incannex Healthcare (IXHL) saw revenue fall 100% in FY2026 to $0 million, operating margin null against a -3.8% median for pharmaceutical preparations, equity 92.3% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1873875 · fiscal year ended 2026-06-30 · 3 audited years read · [page](https://www.pops4.com/boards/company/IXHL) · [JSON](https://www.pops4.com/boards/company/IXHL.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $0 |
| Revenue growth, 1 year | -100.0% |
| Revenue growth per year | — |
| Operating margin | -Infinity% (prior year -27661.6%) |
| Net margin | -Infinity% |
| Operating cash flow | −$13M |
| Capital spending | $10,000 |
| Free cash flow | −$13M |
| Cash | $68M |
| Long-term debt | — |
| Total assets | $73M |
| Total equity | $67M |
| Equity ÷ assets | 92.3% |
| Return on equity | -28.6% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 9.01 (safe zone)
- Piotroski F: 4 of 9 (middling)
- Health Harbor boat: Weathered boat · two warning signs · operating cash flow was negative (-$12.9M in FY2026); operating loss: a margin of -Infinity% in FY2026

## Edgarette's reading

Exposure: revenue $0K (FY2026). Experience: revenue down 100.0% on the year; operating margin null, down from -27661.6%. Soundness: equity 92.3% of assets, return on equity -28.6%. Credibility: 3 audited years, moderate weight. Range: 80% of past cases like this landed between $0K and $0K next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A statistical range, not company guidance. Against peers (114 filers, $50M+ revenue, pharmaceutical preparations): operating margin null against a -3.8% median; growth -100.0% against 13.7%.

Range logged 2026-09-29, receipt 20e1647a08f72087, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 1, latest 2026-03-17 ([filing](https://www.sec.gov/Archives/edgar/data/1873875/000121390026028661/0001213900-26-028661-index.htm))

## Recent filings

- DEF 14A · filed 2026-10-28 · [filing](https://www.sec.gov/Archives/edgar/data/1873875/000121390026113003/0001213900-26-113003-index.htm)
- 10-K · filed 2026-09-25 · [filing](https://www.sec.gov/Archives/edgar/data/1873875/000162828026063506/0001628280-26-063506-index.htm)
- 8-K · filed 2026-09-09 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1873875/000121390026098213/0001213900-26-098213-index.htm)
- 8-K · filed 2026-08-25 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1873875/000121390026093244/0001213900-26-093244-index.htm)
- 8-K · filed 2026-08-11 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1873875/000121390026087493/0001213900-26-087493-index.htm)
- 8-K · filed 2026-07-23 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1873875/000121390026080622/0001213900-26-080622-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001873875.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1873875

## Cite

POPS4, Edgar & Edgarette: Incannex Healthcare Inc. (IXHL) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/IXHL. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.